- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on COPD(Chronic Obstructive Pulmonary Disease) in United Kingdom
Total 18929 results
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Xiromed LLCLaboratorios Liconsa; ExeltisCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Romania, Hungary, Bulgaria, Spain, Finland, Puerto Rico
-
Imperial College LondonCompletedChronic Obstructive Pulmonary Disease | Emphysema | Chronic BronchitisUnited Kingdom
-
NovartisCompletedCOPDUnited States, Argentina, Germany, Spain, Canada, India, Turkey, Sweden, Italy
-
Imperial College LondonCompletedEmphysema | COPD | Chronic BronchitisUnited Kingdom
-
Queen's University, BelfastCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Respivert LtdCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Czechia, Denmark, Hungary, Netherlands, Spain, Korea, Republic of, Argentina, Belgium, Bulgaria, Finland, India, Japan, Mexico, Norway, Sweden, Turkey, Vietnam, Portugal, Puerto Rico
-
AstraZenecaParexelCompletedSafety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University of SouthamptonGlaxoSmithKlineCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
University of LeicesterAparito Ltd.Not yet recruitingChronic Obstructive Pulmonary Disease | Adherence, TreatmentUnited Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Poland, Romania, Canada, Philippines, Spain, Ukraine, Vietnam
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Egypt, Hungary, France, Guatemala, Panama, Slovakia, Slovenia
-
University of VermontNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Dr Ian B WilkinsonUniversity College London Hospitals; Imperial College London; Newcastle University and other collaboratorsRecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
Mrs Hanoof AljohaniUniversity Hospitals, LeicesterRecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Imperial College LondonWithdrawnChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
South Eastern Health and Social Care TrustCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, Netherlands
-
Hull University Teaching Hospitals NHS TrustCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustUnknownChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, China, Spain, Italy, Germany, Belgium, Korea, Republic of, Poland, Taiwan, Israel, New Zealand, Sweden, United Kingdom, Japan, Czechia, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, Brazil, Fran... and more
-
Royal Brompton & Harefield NHS Foundation TrustUnknownChronic Obstructive Pulmonary Disease | EmphysemaUnited Kingdom
-
Imperial College LondonCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
VA Office of Research and DevelopmentCompletedHeart Failure | Chronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States, Korea, Republic of, Argentina, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Canada, India, Bulgaria, Poland
-
NHS TaysideNHS FifeWithdrawnChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
University of LincolnNational Health Service, United KingdomCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Guy's and St Thomas' NHS Foundation TrustCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Northumbria Healthcare NHS Foundation TrustGlaxoSmithKline; Newcastle University; Chiesi UKRecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Hywel Dda Health BoardSwansea UniversityCompleted
-
Respivert LtdCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Michigan; Duke... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of Michigan; Duke... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
MedImmune LLCCompletedPart I (SAD) - Healthy Participants | Part II (MAD) - Chronic Obstructive Pulmonary Disease | Part III (J-SD) - Healthy Japanese ParticipantsUnited Kingdom
-
BioMarck Pharmaceuticals, Ltd.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustNovartisCompleted
-
Chiesi Farmaceutici S.p.A.CompletedA Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 (CHF6001Ext)Chronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Queen Mary University of LondonGlaxoSmithKline; British Lung FoundationCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)CompletedEmphysema | Chronic Obstructive Pulmonary Disease (COPD)United States
-
StratiHealthCompletedChronic Obstructive Pulmonary Disease (COPD)United States